Disease control trial
Bayer, 27 trials, 2021-23. Septoria (T1):
7 trials, 2023. Septoria (T2): 5 trials, 2023. Yellow rust (T1): 9 trials, 2021-23. Brown rust (T2): 5 trials, 2021-23. Eyespot (T1): 1 trial, 2023. University of Nottingham. For eyespot values for Elatus® Era and Univoq® are derived from the prothioconazole component of the product as neither Solatenol® or fenpicoxamid have recognised activity against eyespot.
Note: Elatus® Era not included at T2 as it is not commercial practice to apply Solatenol® for control of Septoria tritici.
T1 targets - Leaf 3 assessments made as BBCH 65
T2 targets - Flag leaf assessments at BBCH 75
Septoria tritici
Bayer, 17 trials spanning 2021-23. Trials performed and assessed by independent partners including Niab, ADAS, OAT, PrimeAg, STC, Velcourt and Envirofield.
Oversprays at T0, T2, and T3. Programmes uniform within trials, not across trials.
Yellow rust
Bayer, 19 trials spanning 2021-23. Trials performed and assessed by independent partners including Niab, STC, SRUC, Eurofins, OAT, Agrochemex and Velcourt. Oversprays at T0, T2 and T3. Programmes uniform within trials, not across trials.
Brown rust
Bayer, 2021-23. Oversprays at T1, no T3. Programmes uniform within trials, not across trials. Univoq®: 5 trials. Revystar®: 5 trials. Elatus® Era: 3 trials. Vimoy® + Proline®: 6 trials.
Eyespot
University of Nottingham, 2023. Assessment under controlled conditions.